AU2002215300A1 - Cancer chemotherapeutical and chemopreventive agent - Google Patents

Cancer chemotherapeutical and chemopreventive agent

Info

Publication number
AU2002215300A1
AU2002215300A1 AU2002215300A AU1530002A AU2002215300A1 AU 2002215300 A1 AU2002215300 A1 AU 2002215300A1 AU 2002215300 A AU2002215300 A AU 2002215300A AU 1530002 A AU1530002 A AU 1530002A AU 2002215300 A1 AU2002215300 A1 AU 2002215300A1
Authority
AU
Australia
Prior art keywords
chemopreventive agent
chemotherapeutical
cancer
cancer chemotherapeutical
chemopreventive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002215300A
Inventor
Choon Nam Ong
Han Ming Shen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National University of Singapore
Original Assignee
National University of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National University of Singapore filed Critical National University of Singapore
Publication of AU2002215300A1 publication Critical patent/AU2002215300A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2002215300A 2000-11-15 2001-11-15 Cancer chemotherapeutical and chemopreventive agent Abandoned AU2002215300A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24896200P 2000-11-15 2000-11-15
US60248962 2000-11-15
PCT/SG2001/000232 WO2002040017A1 (en) 2000-11-15 2001-11-15 Cancer chemotherapeutical and chemopreventive agent

Publications (1)

Publication Number Publication Date
AU2002215300A1 true AU2002215300A1 (en) 2002-05-27

Family

ID=22941456

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002215300A Abandoned AU2002215300A1 (en) 2000-11-15 2001-11-15 Cancer chemotherapeutical and chemopreventive agent

Country Status (3)

Country Link
US (1) US20020058077A1 (en)
AU (1) AU2002215300A1 (en)
WO (1) WO2002040017A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040219229A1 (en) * 2003-04-30 2004-11-04 Tim Clarot Migraine relief composition and methods of using and forming same
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
ATE515262T1 (en) 2003-07-11 2011-07-15 Univ Kentucky Res Found USE OF PARTHENOLIDE DERIVATIVES AS ANTILEUKEMIC AND CYTOTOXIC AGENTS
US7678904B2 (en) 2003-07-11 2010-03-16 University Of Kentucky Use of parthenolide derivatives as antileukemic and cytotoxic agents
KR100798252B1 (en) 2006-01-18 2008-01-24 주식회사 엘지생활건강 C-Kit activation inhibitor, skin whitening compound and composition for skin whitening containing the same
JPWO2008007450A1 (en) * 2006-07-14 2009-12-10 株式会社エム・エム・ティー Food / drink and pharmaceutical composition having tumor suppressive action
WO2008013793A2 (en) * 2006-07-26 2008-01-31 Swaasth, Inc. Luminescence assay utilizing a genetically modified cell line
CN102241684B (en) * 2010-05-11 2014-08-06 天津尚德药缘科技有限公司 Preparation method of parthenolide
CN102863452B (en) * 2011-07-06 2015-05-20 天津尚德药缘科技有限公司 Method for preparing parthenolide originated from magnolia delavayi, magnolia liliiflora and magnolia denudate
BR112014001556A2 (en) * 2011-07-22 2017-02-21 Kalinski Pawel selective chemokine modulation of tumors
KR101320948B1 (en) 2011-11-02 2013-10-22 경희대학교 산학협력단 Compositions for Treatment or Prevention of Cancer Comprising Extract of Chrysanthemum indicum as Active Ingredient
WO2013071066A1 (en) * 2011-11-11 2013-05-16 The Broad Institute, Inc. Signatures associated with the response to cancer therapy
WO2013152032A1 (en) 2012-04-02 2013-10-10 The Regents Of The University Of California Compositions and methods for treating cancer
US20150232856A1 (en) 2012-09-25 2015-08-20 Agency For Science, Technology And Research Telomerase inhibitors for use in therapy
CN104288406A (en) * 2014-11-04 2015-01-21 所俊强 Synergetic medicinal composition for nasopharynx cancer chemoradiotherapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1242071A4 (en) * 1999-12-23 2004-12-29 Advanced Res & Tech Inst Use of parthenolide to inhibit cancer

Also Published As

Publication number Publication date
US20020058077A1 (en) 2002-05-16
WO2002040017A1 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU2001253126A1 (en) (+) naloxone and epinephrine combination therapy
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU2002215300A1 (en) Cancer chemotherapeutical and chemopreventive agent
HK1045462A1 (en) Combined preparations comprising morpholine anthracyclines and anticancer agent
EP1151667A3 (en) Plant-activating agent
AUPQ155799A0 (en) Therapeutic methods and uses
AU2002354410A1 (en) Triazole compound and medicinal use thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2002234773A1 (en) Pharmaceutically effective ginsenosides and their use
AU2001267213A1 (en) Cdna for human methylenetetrahydrofolate reductase and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002234165A1 (en) Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
AU2001278738A1 (en) Medicinal compositions for preventing and treating cancer
AU2001257325A1 (en) Cancer treatment
AU2001275696A1 (en) Therapeutic agent
AU2001252235A1 (en) A composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
AU2669201A (en) Taccalonolides and their use
AU2001235364A1 (en) Tetrahydronaphtalene derivatives and their use
AU2002250668A1 (en) Crushing body comprising concave portions
AU2694200A (en) Itchiness-relieving agents and itchiness-relieving effect potentiators
AU2001237518A1 (en) Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application